Skip to main content
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

COVID-19 In Vitro Diagnostic Medical Device - detail



SARS-CoV-2 Antigen Quantitative Assay Kit (Enzyme-linked Immunoassay)

Manufactured by Biohit Healthcare (Hefei) Co.,Ltd., China - www.biouhan.com 

Device identification number
1293
CE Marking
Yes
HSC common list (RAT)
×No
Format
Near POC / POC
Physical Support
Cassette
Target type
Antigen
Antibody type
Monoclonal
Targets
nucleocapsid protein,
Specimen
Plasma, Serum
Cross-reactivity (pathogens tested)
Adenovirus, Chlamydia Pneumoniae, Cytomegalovirus (CMV), Epstein-Barr Virus (EBV), Hepatitis C Virus (HCV), Herpes Simplex (HSV), Human Immunodeficiency Virus (HIV), Influenza A, Influenza B, Influenza B Yamagata, Mycoplasma Pneumoniae, Parainfluenza Virus Type, Respiratory Syncytial V (RSV), Varicella Zoster Virus (VZV)
Pathogens detected
Adenovirus, Chlamydia Pneumoniae, Cytomegalovirus (CMV), Enterovirus A71 (EV-A71), Epstein-Barr Virus (EBV), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Herpes Simplex (HSV), Human Immunodeficiency Virus (HIV), Influenza A, Influenza B, Mycoplasma Pneumoniae, Parainfluenza Virus Type, Respiratory Syncytial V (RSV), Varicella Zoster Virus (VZV)
Lineages detected
B.1.1.7 (Alpha), B.1.351 (Beta), B.1.427 (Epsilon), B.1.429 (Epsilon), B.1.617.1 (Kappa), B.1.617.2 (Delta), C.37 (Lambda), P.1 (Gamma), B.1.1.529 (Omicron),
Commercial Status
Commercialised
Last Update
2022-04-20 12:09:38 CET
Comments
This kit is used for quantitative detection of SARS-CoV-2 nucleocapsid protein (N protein) in human serum or plasma. Antigen epitope information: N‐terminal domain (NTD; 46 –176 aa) C‐terminal domain (CTD; 247–364 aa)
Assay Type
Immuno-Antigen
Rapid Diagnostic
No
Self Test
No
Reader Required
Yes
Subcategory
Other
Method
ELISA
Measurement
Quantitative
Time
75 minutes
Subclass
Sandwich, Double
LOD
2.97 (pg/mL)
Calibration
Evaluated
Calibration
Evaluated
Crossreactivity
Evaluated
Crossreactivity
Evaluated
Fp
0 %
Fn
0 %
Precision
Evaluated
Accuracy
99.33 %
Accuracy
99.33%
Reproducibility
Evaluated
Robustness
Evaluated
Clinical Sensitivity
95.05 %
Clinical Specificity
100 %
Type of antigen
Nucleocapsid protein

The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements